Strong New Patient Growth
New patient starts increased by 79% over the prior year and 37% from Q1, indicating strong adoption of Eversense 365.
Significant Direct-to-Consumer (DTC) Marketing Impact
Leads more than doubled over the prior year, with June leads up 50% over the prior 3-month average, showcasing effective marketing strategies.
Revenue Growth
Net revenue grew 37% to $6.6 million compared to $4.9 million in the prior year period, driven by new Eversense 365 insertions.
Improved Gross Profit Margins
Gross profit was $3.1 million, an increase of $2.8 million from the prior year, due to increased margins and sales channel mix.
Strong Financial Position
Cash position of over $126 million after raising approximately $78 million in the second quarter, supporting ongoing projects.
Successful Integration with Sequel's Twiist Pump
The integration is expected to simplify diabetes management and offer unique benefits to users.